PROGRAM
The committee is excited to announce the program is now available. This will continue to be updated as details are confirmed, please note this is subject to change without notice.
For details on how to claim points for Continuing Professional Development (CPD) for attendance at the APSAD 2022 Conference, click here.
Click on the tabs below to view the program for each day. All times are in Australian Central Standard Time (ACST) Darwin, unless stated otherwise.
08:30 – 10:55
Opening Plenary
HYBRID SESSION
Welcome to Country
Conference Welcome
Cassandra Wright, Research Fellow
Menzies School Of Health Research, NT
and
Peter Burnheim, Executive Officer
Association of Alcohol & Other Drug Agencies, NT
and
Sarah Clifford, PhD Student
Menzies School Of Health Research, NT
Ministerial Address
The Hon Natasha Fyles MLA, Chief Minister of the Northern Territory
APSAD President’s Address
Leanne Hides, Lives Lived Well Chair Of Alcohol, Drugs & Mental Health
The University Of Queensland, QLD
First Nations Australians’ self-determination in alcohol policy. Is it possible?
Keynote Speaker: Annalee Stearne, Research Associate
National Drug Research Institute, WA
Poster Highlights
Reaching consensus on the most important measures of performance for NSW non government alcohol and other drugs treatment services
Robert Stirling, CEO
Network of Alcohol and Other Drug Agencies, NSW
COVID-19 pandemic experiences of people in Australia who inject drugs: Analysis of Illicit Drug Reporting System interview data 2020-2022
Olivia Price, PhD Candidate
National Drug and Alcohol Research Centre, NSW
The effectiveness of psychosocial interventions for family members impacted by another’s substance use: A systematic review of the last 10 years
Clare Rushton, PhD Candidate
University Of Wollongong, NSW
Outback Quit Pack pilot RCT trial: mailout NRT and Quitline support for people in rural, regional and remote areas who smoke
Ashleigh Guillaumier, Research Fellow
University of Newcastle, NSW
Interactions between Methadone and Rifampicin: a case series
Jeku Jacob, Addiction Medicine Trainee
St Vincent’s Hospital, Sydney, NSW
Patient-reported outcomes of subcutaneous depot buprenorphine treatment in Australian correctional centres
Bethany White, Clinical Trial Manager
Edith Collins Centre, SLHD, NSW
“Sometimes I Have a Duty of Care Not to Call 000”: Reported Practices, Attitudes and Factors Influencing Consumer Responses to GHB Overdose
Jack Freestone, Manager Drug And Alcohol Research And Development
ACON, NSW
VEND-C. Evaluating distribution of rapid HCV-antibody self-testing kits via needle/syringe vending machines: A protocol paper
Caitlin Douglass, Research Officer
Burnet Institute and Menzies School of Health Research, VIC
Law Enforcement Assisted Diversion (LEAD): Why utilising a harm reduction and community care approach is proving a valuable tool to heal the decades of harm caused by America’s War on Drugs; One city at a time
Keynote Speaker: Najja Morris-Frazier, Director
LEAD Support Bureau, USA
and
Keynote Speaker: Brendan Cox, Director of Policing Strategies
LEAD Support Bureau, USA
10:55 – 11:25
Morning Tea
11:25 – 12:30
Concurrent Session 1A
Strengthening Services
HYBRID SESSION
Concurrent Session 1B
Opioid Treatment
HYBRID SESSION
Concurrent Session 1C
PIEDS
IN PERSON ONLY
Concurrent Session 1D
Alcohol
IN PERSON ONLY
Capacity building for outcome evaluations: lessons learned using participatory methods to develop a routine data collection protocol within two Aboriginal and Torres Strait Islander AOD residential rehabilitation services in Queensland
Katinka van de Ven, Senior Lecturer
University of New England, QLD
Recruitment, retention and wellbeing in the alcohol and other drug sector
Elisabeth Yarbakhsh, Researcher
ATODA, ACT
Feasibility and effectiveness of implementing a clinical supervision exchange program in the Australian alcohol and other drugs sector
Courtney O’Donnell, Sector and Workforce Development Officer
Queensland Network of Alcohol and Other Drug Agencies, QLD
Identity, skills and development of managers and leaders in the alcohol and other drugs sector
Robert Stirling, CEO
Network of Alcohol and Other Drug Agencies, NSW
The experiences of affected family members and friends attending BreakThrough: Families Understanding Addiction
Annette Peart, Research Fellow
Monash University, VIC
Partners in language: Working collectively to address stigma
Alison Lai, CEO
Alcohol, Tobacco and Other Drugs Council, TAS
Q&A
Exploring consumer experience and satisfaction with depot buprenorphine formulations: A mixed-methods study
Sona Samadian, Senior Pharmacist, DASSA Pharmacies Site Supervisor& DTC Chair
SA Health, DASSA, SA
Preliminary analyses of opioid prescribing patterns following prescription drug monitoring program implementation in Victoria: A time series analysis
Louisa Picco, PhD Candidate
Monash University, VIC
Options Study: Exploring Patients’ Experiences with Depot Buprenorphine and their Motivations to Discontinue
Simon Clay, Postdoctoral Research Fellow
National Drug & Alcohol Research Centre, UNSW Sydney, NSW
Persistent opioid use following surgical discharge: a prescription data linkage study comparing tapentadol and oxycodone as initial discharge opioid type
Tina Lam, Senior Research Fellow
Monash Addiction Research Centre, VIC
Correlates of high-dose opioid prescribing pre and post Prescription Drug Monitoring Program implementation in Victoria
Ting Xia, Research Fellow
Monash Addiction Research Centre, VIC
Consumer and pharmacist experiences of opioid agonist treatment in New South Wales community pharmacies
Theresa Caruana, PhD Candidate
UNSW Centre For Social Research In Health, NSW
Q&A
Extending the efficacy of harm reduction frameworks for steroid users in Australia
Timothy Piatkowski, Lecturer
Charles Darwin University, NT
Are performance and image enhancing drugs an issue of concern in women?
Matthew Dunn, Senior Lecturer
Deakin University, VIC
Needle exchange staff perspectives and knowledge about the injection of performance and image enhancing drugs, and the clients using these substances
Rhys Ponton, Senior Lecturer
School Of Pharmacy, University Of Auckland, New Zealand
What are the reported adverse effects of Performance and Image Enhancing Drugs use? – Data from the PUSH! Study
Beng Eu, GP and Co-director
Prahran Market Clinic, VIC
How to manage and minimise harm for people who are contemplating, currently using or wanting to stop non-prescribed steroid and other performance and image enhancing drug use
Katinka van de Ven, Senior Lecturer
University Of New England, NSW
Q&A
Influences on parental alcohol supply and non-supply decisions: Qualitative insights
Jacqueline Bowden, Director
National Centre for Education and Training on Addiction (NCETA)
Twelve-month Outcomes of a Two-Stage Social Network Intervention Aimed at Reducing Heavy Drinking among Residential College Students
Lily Davidson, PhD Candidate
University of Queensland, QLD
“It works like a gateway drug… they start on the zero alcohol and they want to try the real thing”: Perceptions of zero-alcohol beverages and their use by adolescents
Nathan Harrison, Senior Research Officer
National Centre For Education And Training On Addiction (NCETA), SA
Moderate alcohol consumption and depression: A marginal structural model analysis of a representative US cohort
Rachel Visontay, PhD Candidate
The Matilda Centre For Research In Mental Health And Substance Use, The University Of Sydney, NSW
Impulsivity and Vulnerability for Transition from Binge Drinking to Alcohol Use Disorder
Antoinette Poulton, Research Fellow
University Of Melbourne, VIC
Generational shifts in attitudes and beliefs about alcohol: an age-period-cohort approach
Michael Livingston, Associate Professor
National Drug Research Institute, VIC
Re-thinking how we ask Aboriginal and Torres Strait Islander peoples about their drinking
Kylie Lee, Associate Professor/Deputy Director
The University of Sydney, NSW
and
Scott Wilson, CEO
Aboriginal Drug and Alcohol Council South Australia, SA
Q&A
12:25 – 13:25
Lunch
12:30 – 13:20
Lunch Workshop
IN PERSON ONLY
“What do I say? How do I say it?” Twitter as a knowledge dissemination tool for Australian mental health and substance use research
Louise Thornton, Senior Research Fellow
The Matilda Centre For Research In Mental Health And Substance Use, The University Of Sydney, NSW
13:25 – 15:20
Afternoon Plenary
HYBRID SESSION
Ketamine Assisted Therapy in the Treatment of Drug and Alcohol Problems
Keynote Speaker: Celia Morgan, Professor of Psychopharmacology
University of Exeter, United Kingdom
APSAD Awards
Take Home Naloxone – Learning from practice and evaluation, looking forward to broad implementation
Keynote Speaker: Caroline Salom, Principal Research Fellow
Institute For Social Science Research, UQ, Queensland
and
Keynote Speaker: Paul Dessauer, Outreach Coordinator
Peer Based Harm Reduction WA, WA
15:20 – 15:50
Afternoon Tea
15:50 – 16:55
Concurrent Session 2A
Prenatal Alcohol Exposure/FASD
HYBRID SESSION
Concurrent Session 2B
Novel Treatment
HYBRID SESSION
Concurrent Session 2C
Primary & Community Healthcare
IN PERSON ONLY
Concurrent Session 2D
Alcohol in Digital Media
IN PERSON ONLY
Are Australians aware of the risks of drinking during pregnancy and breastfeeding? Results of a baseline survey prior to a national campaign
Joanna Caruso, National Evaluation Coordinator
Health Policy Centre, South Australia Health and Medical Research Institute, SA
The Effect of Drinking during Pregnancy on Child Behavioural Health Outcomes and Associated Costs
Brenda Gannon, Professor and Director of Research
University of Queensland, QLD
Prevalence of substance use among incarcerated pregnant women in New South Wales
Sobi Kim, Nurse Practitioner
Justice Health and Forensic Health Network of NSW, NSW
Development of Aotearoa (New Zealand) diagnostic guidelines for Fetal Alcohol Spectrum Disorder
Andi Crawford, Clinical Psychologist
Hāpai Te Hauora, New Zealand
and
Sarah Goldsbury, Clinical Psychologist
Hāpai Te Hauora, New Zealand
Evaluation of the FAD Hub Australia Website
Elizabeth Elliot, Professor of Paediatrics and Child Health
University of Sydney, NSW
Q&A
Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot safety and feasibility trial
Liam Acheson, Research Officer
St Vincent’s Hospital Sydney, NSW
What can we learn from history about using psychedelic drugs to treat addiction?
Wayne Hall, Emeritus Professor
The National Centre for Youth Substance Use Research, the University of Queensland, QLD
Buprenorphine micro-dosing for methadone-buprenorphine transfers
Chris Tremonti, Staff Specialist
St Vincent’s Health, NSW
Lessons from the evaluation of a novel web-app to assist Aboriginal and Torres Strait Islander people to reduce or stop using methamphetamine: We Can Do This
Rachel Reilly, Senior Research Fellow
SAHMRI, SA
Feasibility and acceptability of Eye Movement Desensitisation and Reprocessing interventions in a public drug and alcohol service
Adrian Dunlop, Director and Senior Staff Specialist
HNE Health – Drug And Alcohol Clinical Services, NSW
Designing and implementing a home withdrawal service in South East Sydney in response to COVID
Lynsey Mckendrick, Clinical Nurse Specialist
South Eastern Sydney Local Health District, NSW
Q&A
A qualitative exploration of client and healthcare provider perspectives on why people who inject drugs with injecting-related infections discharge against medical advice
Brendan Clifford, Clinical Research Coordinator
St Vincent’s Hospital Sydney, NSW
Integrating brief alcohol reduction interventions into chronic disease care in South Africa: findings from a cluster randomized controlled trial
Bronwyn Myers, Director Curtin Enable Institute
Curtin University, WA
Implementation, sustainability, client and service outcomes of delivering the First Step brief intervention in community AOD settings
Leanne Hides, Lives Lived Well Chair Of Alcohol, Drugs & Mental Health
The University Of Queensland, QLD
Prescription Opioid Use Disorder in patients prescribed opioids for chronic pain: a diagnostic challenge for Australian General Practitioners
Hester Wilson, Doctor
SESLHD DAS, NSW
Engaging men who perpetrate domestic and family violence in the alcohol and other drugs treatment context
Michelle Ridley, Clinical Program Manager
Network Of Alcohol And Other Drugs Agencies, NSW
Q&A
Commercial Determinants of Health
Mark Petticrew
Symposium: Exposure to alcohol in digital media: Why it matters and what can be done
Emmanuel Kuntsche, Director
Centre For Alcohol Policy Research, VIC
and
Benjamin Riordan, Research Fellow
Centre Of Alcohol Policy Research, La Trobe University, Melbourne, VIC
and
Dan Anderson-Luxford, Research Officer
Centre Of Alcohol Policy Research, La Trobe University, Melbourne, VIC
and
Paula O’Brien, Associate Professor
Melbourne Law School, The University of Melbourne, VIC
17:10 – 19:00
Drug and Alcohol Review Editorial Board Meeting
Invitation Only
17:45 – 19:30
Camurus Sponsored Symposoium
HYBRID SESSION
Open to Australian HCPs only
Camurus invite you to join a panel of Australian experts including Professor Nick Lintzeris, Professor Adrian Dunlop, Dr Mary Harrod and Dr Craig Rogers to explore how long-acting injectable buprenorphine (LAIB) has impacted the treatment of opioid dependence in Australia. They will unpick the challenges, access, and explore ways to optimise care for people living with opioid dependence. The 4 key areas for the discussion include, the role of digital health, the role of pharmacy, integration of LAIB into services and the perspective of the service users.
07:30 – 08:50
Early to Mid Career Researcher Networking Breakfast
IN PERSON ONLY
09:00 – 10:55
Morning Plenary
HYBRID SESSION
James Rankin Oration
“The more things change…” – Reflections on the journey
Keynote Speaker: Kate Conigrave, Professor/Senior Staff Specialist
RPA Hospital/The University of Sydney, NSW
APSAD Awards
Managed Alcohol Programs: Can giving alcohol to heavy drinkers be harm reducing?
Keynote Speaker: Tim Stockwell, Emeritus Professor
Canadian Institute for Substance Use Research, Canada
10:55 – 11:25
Morning Tea
11:25 – 12:35
Concurrent Session 3A
First Peoples
HYBRID SESSION
Concurrent Session 3B
Young People & Festivals
HYBRID SESSION
Concurrent Session 3C
Collaborative Care
IN PERSON ONLY
Concurrent Session 3D
Substance Use Epidemiology
IN PERSON ONLY
Alcohol and other drug use of Aboriginal people involved in the NSW criminal justice system
Michael Doyle, Senior Research Fellow
The Centre of Research Excellence in Indigenous Health and Alcohol, University of Sydney, NSW
Symposium: Pathways for Aboriginal and Torres Strait Islander peoples to lead the way in alcohol research
Michael Doyle, Senior Research Fellow
The Centre of Research Excellence in Indigenous Health and Alcohol, University of Sydney, NSW
and
Lynette Bullen, Senior Drug And Alcohol Clinician
Western NSW Local Health District, NSW
and
Teagan J. Weatherall, PhD Student
The University of Sydney, NSW
and
Annalee Stearne, Research Associate
National Drug Research Institute
Workshop: Young people in AOD spaces: participation in advocacy, research, practice and policy
Isabelle Volpe, PhD Candidate
UNSW Sydney, NSW
and
Nick Kent, Director
Students for Sensible Drug Policy Australia
and
Bee Hayes, DanceWize Program Coordinator
Harm Reduction Victoria, VIC
Symposium: Drug related harms and responses at NSW music festivals: Then, now and where to next
Jessica Harper, Senior Project Officer
NSW Health, NSW
and
James Wilson, Senior Project Officer, AOD Harm Reduction
NSW Ministry of Health – Centre For Alcohol and Other Drugs, NSW
and
Thanjira Jiranantakan, Medical Advisor
Centre for Alcohol & Other Drugs, NSW Ministry of Health, NSW
and
Mary Harrod, CEO
NSW Users and AIDS Association, NSW
Is Integrated Care still achievable? Implementing an innovative co-design approach across specialist Mental Health and Alcohol and Other Drug services
Sandra Sunjic, Project Manager
USyd and Drug & Alcohol Services, South Eastern Sydney Local Health District And Discipline Of Addiction Medicine, USYD, NSW
Opportunistic Oral Health Care with Silver Flouride in a Medically Supervised Injecting Room
Nico Clark, Medical Director
North Richmond Community Health, VIC
“Literally lifesaving and transformational”: key stakeholders’ views of an assertive outreach support pilot
Jane Fischer, Research Fellow
National Centre For Education And Training On Addiction (NCETA)
Expanded access to naloxone among police officers: is it effective?
Seraina Agramunt, Research Associate
National Drug Research Institute, EnAble Institute, Curtin University, WA
“Making Better, Better – Reviewing and Improving Our Assertive Community Management Services Model of Care”
Kylie Tustian, Senior Social Worker
SESLHD, NSW
Managing Suicidal Crisis at the Sydney Medically Supervised Injecting Centre (MSIC)
Kate Hocknull, Clinical Nurse Consultant
Uniting MSIC, NSW
Q&A
People living with HIV who inject or have injected non-prescription drugs: evidence of substantial differences in health inequalities and experiences of clinical care
Thomas Norman, Research Officer
La Trobe University, VIC
Poisonings from hydrocarbon inhalant misuse in Australia
Jared Brown, Manager, Toxicity Response, Epidemiology And Surveillance
Centre For Alcohol and Other Drugs, NSW Ministry of Health, NSW
Intersections between gambling participation, alcohol and illicit substance use, mental ill-health and other harms among Australian males
Rebecca Jenkinson, Senior Research Fellow
Australian Gambling Research Centre, Australian Institute Of Family Studies, VIC
Age, period, and cohort effects on alcohol-related risky behaviours in Australia from 2001 to 2016
Wing See Yuen, PhD Candidate/Research Officer
National Drug And Alcohol Research Centre, NSW
Surveillance of kava-related emergency department presentations in NSW
Therese Ryan, Senior Epidemiologist
NSW Ministry of Health, NSW
From the Jungle to The Street: Country-level variation and demographic correlates of cocaine prices
Cheneal Puljevic, Research Fellow/ Research Operations Manager
The University Of Queensland, QLD
Australian’s Alcohol Use is Decreasing but has Alcohol-related Absenteeism?
Alice Mcentee, Research Fellow
Flinders University, SA
Q&A
12:35 – 13:30
Lunch
12:40 – 13:25
Lunch Workshop
IN PERSON ONLY
Beyond debriefing: The importance of reflective practice and supervision in the wellbeing of Alcohol and Other Drug (AOD) workers
Hoiyan Karen Li, Advanced Clinical Educator/Clinical Psychologist
Insight, Queensland Health/Couragepsyc, QLD
12:40 – 13:30
Australian Government’s Engagement with Civil Society on International Drug Policy Matters
IN PERSON ONLY
13:30 – 14:15
Afternoon Plenary
HYBRID SESSION
Vaping Regulation: can we find the right balance for greatest public health benefit?
Keynote Speaker: Hayden McRobbie, Professor in Public Health Interventions
University of New South Wales, NSW
Late Breakers
Ketamine overdose among people who regularly use ecstasy and other illicit stimulants in Melbourne, Victoria
Joanna Wilson, Research Assistant
Burnet Institute, VIC
Fetal Alcohol Spectrum Disorder Australian Registry: Informing practice and policy
Elizabeth Elliott, Professor Of Paediatrics And Child Health
University Of Sydney, NSW
Unregistered benzodiazepines and counterfeit alprazolam in NSW
Jared Brown, Manager, Toxicity Response, Epidemiology And Surveillance
Centre For Alcohol and Other Drugs, NSW Ministry of Health, NSW
How Are Tobacco Purchasing and Financial Stress Related? A Cross Sectional Study of Australian Household Survey Data
Rowan Dowling, PhD Candidate
Centre Of Alcohol Policy Research, La Trobe University, VIC
14:45 – 15:45
Poster Tour Sessions
IN PERSON ONLY
15:30 – 15:45
Afternoon Tea
15:45 – 16:55
Concurrent Session 4A
Tobacco
HYBRID SESSION
Concurrent Session 4B
Minimum Unit Pricing
HYBRID SESSION
Concurrent Session 4C
Women & Alcohol
IN PERSON ONLY
Concurrent Session 4D
Injecting
IN PERSON ONLY
Analysis and lessons learnt about the implementation of the SISTAQUIT smoking cessation trial in pregnant Aboriginal and Torres Strait Islander women
Gina La Hera Fuentes, Student
The University of Newcastle, NSW
Investigating the associations between e-cigarette use and cigarette smoking among young adults in Australia
Emma Devine, Postdoctoral Research Fellow
University Of Sydney, NSW
Nicotine vaping among Quitline clients: analysis of counsellor observations following the introduction of the prescription model for nicotine vaping in October 2021
Cathy Segan, Behavioural Scientist
Cancer Council Victoria, VIC
Has regulating e-cigarettes impacted their use among a sample of people who use ecstasy and/or other stimulants? Findings from the Ecstasy and Related Drugs Reporting System
Rachel Sutherland, Research Fellow
National Drug and Alcohol Research Centre, NSW
Ready to Ditch the Vape? Supporting Adolescents and Young Adults to quit vaping
Mary Wahhab, Clinical Nurse Consultant
SCHN, NSW
How feasible is contingency management-based tobacco treatment for pregnant women with substance use concerns?
Melissa Jackson, Clinical Research Coordinator/PhD Candidate
Hunter New England Local Health District Drug & Alcohol Clinical Services, NSW
Q&A
Symposium: Minimum Unit Pricing
Tim Stockwell, Emeritus Professor
Canadian Institute for Substance Use Research, Canada
and
Nicholas Taylor, Research Fellow
National Drug Research Institute, VIC
and
Cecelia Gore, Mental Health and AOD Branch, NT Health
and
John Holmes, School of Health and Related Research, University of Sheffield, UK
Leveraging sober curiosity to support affluent midlife women toward alcohol reduction
Belinda Lunnay, Research Associate
Torrens University, SA
Alcohol consumption among an Australian cohort of women eligible to participate in the national breast screening program
Peta Stragalinos, Research Assistant
Turning Point, VIC
Women’s experiences of an alcohol brief intervention in the breast screening setting: A qualitative study
Peta Stragalinos, Research Assistant
Turning Point, VIC
‘Ripple’ – An online intervention aiming to reduce alcohol use in middle-aged women: Results of a Randomised Controlled Trial
Sandra Kuntsche, Principal Research Fellow
Centre For Alcohol Policy Research, La Trobe University, VIC
“We were all stuffed.” Working mother’s alcohol consumption during the COVID-19 lockdowns: A qualitative analysis
Maree Patsouras, PhD Candidate
Centre For Alcohol Policy Research, La Trobe University, VIC
Q&A
The Impact of COVID-19 on Supervised Injecting Facilities in Australia
Amanda Roxburgh, NHMRC Research Fellow
Burnet Institute, VIC
Reviewing the impacts of the Melbourne Supervised Injecting Room
Paul Dietze, Professor
National Drug Research Institute, VIC
Two years of overdose in Melbourne’s Medically Supervised Injecting Room, June 2018 to June 2020
Shelley Cogger, Policy And Projects
North Richmond Community Health Medically Supervised Injecting Room, VIC
Healthcare, drug treatment and harm reduction service access for people who use and inject drugs during the COVID-19 pandemic
Shelley Walker, Research Fellow
Burnet Institute, VIC
Uptake of COVID-19 vaccination among people who inject drugs in Australia
Lisa Maher, Professor And Program Head
Kirby Institute For Infection And Immunity, Faculty Of Medicine, UNSW Sydney, NSW
Q&A
17:00 – 18:30
APSAD Annual General Meeting
Open to all APSAD Members
19:00 – 22:00
APSAD Conference Dinner
09:00 – 10:05
Concurrent Session 5A
Drug Policy Reform
HYBRID SESSION
Concurrent Session 5B
Opioids & Stimulants
HYBRID SESSION
Concurrent Session 5C
Prevention & Treatment
IN PERSON ONLY
Concurrent Session 5D
Alcohol Policy
IN PERSON ONLY
Workshop: Getting What Our Sector Needs – How to Campaign for Change
Alice Salomon, Social Justice Lead
Uniting NSW/ACT, NSW
Outcomes for clients in opioid treatment programs who use amphetamine type substances: Results from a retrospective analysis of routinely-collected clinical data
Llewellyn Mills, Senior Research Associate
South Eastern Sydney Local Health District, NSW
Changes in tobacco smoking frequency following exposure to smoke-free prisons among men who regularly injected drugs
Michael Curtis, PhD Candidate
Burnet Institute, VIC
Michael Curtis, PhD Candidate
Burnet Institute, VIC
Treatment-seeking in stimulant users: The role of biosocial cognitive factors
Angela Wanigasooriya, PhD Student
National Centre for Youth Substance Use Research, QLD
Long-term patterns of heroin use and mental health: findings from the 18-20-year follow-up of the Australian Treatment Outcome Study (ATOS)
Christina Marel, Senior Research Fellow
The University Of Sydney, NSW
Long-term physical health outcomes of heroin dependence
Chris Tremonti, Staff Specialist
St Vincent’s Health, NSW
Q&A
Youth Services Program: Lessons from a comprehensive program review
Amanda Davies, Senior Consultant
360Edge, NT
Baseline in the Grass: Alcohol, drug use and harm reduction practices among festival attendees
Caitlin Douglass, Research Officer
Burnet Institute and Menzies School of Health Research, VIC
OurFutures: Universal prevention programs for adolescents targeting substance use and mental ill-health
Amy-Leigh Rowe, Research Associate
The Matilda Centre, The University Of Sydney, NSW
Implementing a smoke-free policy in alcohol and other drug residential treatment facilities: Qualitative exploration of staff perceptions
Zoe Walter, Lecturer
The University Of Queensland, QLD
Development of a video for families and friends of people with alcohol or drug concerns
Siyu Qian, Research Project Officer
Islhd Drug And Alcohol Service, NSW
Perceptions of combination nicotine replacement therapy and vaporised nicotine product use for tobacco smoking cessation following discharge from alcohol and other drug residential withdrawal services: A qualitative analysis
Joshua Trigg, Research Fellow Public Health
Flinders University, SA
How can a new formulation reduce stigma linked to opiate agonist treatment?: Place, time and things in the experience of extended-release buprenorphine depot
Carla Treloar, Scientia Professor, Director
Centre For Social Research In Health, UNSW Sydney, NSW
Q&A
The handling of gender in research and policy on alcohol and nightlife violence: Findings from an international comparative study of Australia, Canada and Sweden
David Moore, Professorial Research Fellow
La Trobe University, VIC
and
Helen Keane, Professor of Sociology
Australian National University, ACT
Research Into Action: Examining ‘hotspots’ of alcohol and drug-related harm
Michael McGrath, Research Fellow
Turning Point, VIC
Exploring previously unstudied effects of late-night restrictions on licensed venues on family and domestic violence
Michala Kowalski, PhD Candidate
Drug Policy Modelling Program, UNSW Sydney, NSW
What are the impacts of alcohol supply reduction measures on police-reported adult domestic and family violence in the Northern Territory of Australia?
Sarah Clifford, PhD Student
Menzies School Of Health Research, NT
Ethical issues in alcohol policy in Australia: A key informant interview study
Mary Jean Walker, Lecturer
La Trobe University, VIC
Q&A
10:00 – 10:30
Morning Tea
10:30 – 12:35
Morning Plenary
HYBRID SESSION
Understanding Addiction Through Whakapapa: Recognition of Collective Trauma and Colonisation Through an Indigenous Maōri Lens
Keynote Speaker: Khylee Quince, Dean
Auckland University of Technology, New Zealand
APSAD Awards
All Sorts! Using new and emerging technology to understand young adults’ celebratory and event-specific drinking
Keynote Speaker: Ben Riordan, Research Fellow
Centre For Alcohol Policy Research, VIC
Poster Highlights
Can a telephone-delivered intervention for methamphetamine use problems overcome barriers to treatment?
Rachel Petukhova, Research Assistant
Turning Point, VIC
A study protocol for the PsiMA trial: Psilocybin assisted Psychotherapy for Methamphetamine use disorder
Elizabeth Knock, Clinical Psychologist
St Vincents Hospital Sydney, NSW
Childhood maltreatment and alcohol problems in young adulthood: coping style as a mediator and potential intervention target
Lucinda Grummitt, PhD Student And Research Assistant
The University Of Sydney, NSW
Microdosing amongst people who regularly use ecstasy and other illicit stimulants in Australia, 2021-2022
Caroline Salom, Principal Research Fellow
Institute For Social Science Research, UQ, QLD
Do eHealth interventions targeting poor diet, alcohol use, tobacco smoking and vaping adequately serve adolescents from disadvantaged backgrounds? Findings from a systematic review
Lyra Egan, Research Assistant and PhD Candidate
The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, NSW
A Medically Supervised Injecting Room as a gateway to health and social support
Nico Clark, Medical Director
North Richmond Community Health, VIC
Prevalence of substance use in non-transport injury events
Georgina Lau, PhD Candidate
Monash University, VIC
12:35 – 13:35
Lunch
13:35 – 14:45
Concurrent Session 6A
Strength in Lived Experience
HYBRID SESSION
Concurrent Session 6B
Comorbidity
HYBRID SESSION
Concurrent Session 6C
Cannabis & Law Reform
IN PERSON ONLY
Concurrent Session 6D
Approaches to AOD Screening and Data Collection
IN PERSON ONLY
MSIC Consumer Action Group – Nothing About Us Without Us
Kevin Street, Consumer Action Group Member
Uniting MSIC Consumer Action Group
Understanding, utilising and supporting the contributions of AOD workers with lived experience
Anke van der Sterren, Senior Research Manager
Alcohol Tobacco and Other Drug Association ACT, ACT
Changing attitudes of the general public towards people with prison and injecting drug use histories: A research-informed, co-designed, arts-based intervention
Carla Treloar, Scientia Professor, Director
Centre For Social Research In Health, UNSW Sydney, NSW
A consultation on safety and amenity with people who use drugs in North Richmond, Australia
Shelley Cogger, Policy And Projects
North Richmond Community Health Medically Supervised Injecting Room, VIC
Can we save more lives? A new approach to providing take-home naloxone
Sandra Sunjic, Project Manager
Discipline of Addiction Medicine, Central Clinical School University of Sydney; Drug and Alcohol Services, South Eastern, NSW
The Rock Solid Project: A peer education project to reduce methamphetamine related harms amongst people who use drugs
Rebecca Biglane, Coordinator – Health Promotion And AOD
Q&A
Symposium: Comorbidity: Trauma, substance use and mental health
Logan R. Harvey, Clinical Psychologist/PhD Candidate
The Matilda Centre – University Of Sydney, NSW
and
Shalini Arunogiri
and
Natalie Peach, Postdoctoral Research Fellow
University Of Sydney, NSW
The long-term impact of post-traumatic stress disorder on recovery from heroin dependence
Katherine Mills, Director Of Early Intervention And Treatment Research
The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, NSW
Survey of people who create their own vaporisable cannabis products and repurpose already vaped bud
Grace Gschwend, Student
University of Wollongong, NSW
An association between cannabis use frequency and experience of depression among adult Australian males: A prospective cohort study
Brendan Quinn, Research Fellow
Australian Institute Of Family Studies, VIC
The persistence of criminal penalties for drug use and possession: the role of evidence, public opinion and problem framing in Victorian Inquiry recommendations, 1996 to 2018
Keelin O’Reilly, Research Officer
Drug Policy Modelling Program, UNSW, NSW
Prevalence and correlates of positive parental attitudes towards cannabis use and use intention in Australia during 2016 and 2019
Vivian Chiu, PhD Candidate
University of Queensland, QLD
Assessing the public health impacts of cannabis legalisation in Canada
Janni Leung, Research Fellow
National Centre For Youth Substance Use Research, QLD
What is the hype on #MedicinalMarijuana in the USA? A Twitter based analysis
Carmen Chia Wern Lim, PhD Candidate
National Centre For Youth Substance Use Research, The University of Queensland, QLD
Legislative reform to eliminate discrimination against people who use drugs
Devin Bowles, Chief Executive Officer
Alcohol Tobacco And Other Drug Association ACT, ACT
Q&A
Supporting Aboriginal Community Controlled Health Services in screening and alcohol care: where to from here?
Kate Conigrave, Professor/Senior Staff Specialist
RPA Hospital/The University of Sydney, NSW
and
Robert Assan, Senior Health Worker
Queensland Health, QLD
Definition Matters: Assessment of tolerance to the effects of alcohol in a prospective cohort study of emerging adults
Siobhan O’Dean, Postdoctoral Research Fellow
The Matilda Centre For Research In Mental Health And Substane Use, University Of Sydney, NSW
Translation and Cultural Adaptation of the World Health Organization’s Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) into Pitjantjatjara
Matthew Stevens, Research Fellow
University Of Adelaide, SA
Developing a CALD Audit Tool for AOD Services: Experiences from four pilot sites
Tata de Jesus, Program Manager
NADA, NSW
The association between exposure to mother’s and father’s alcohol use and children’s normative perceptions
Megan Cook, Research Officer
Centre for Alcohol Policy Research, VIC
Can my smartphone tell what I had to drink last night? Systematic review of the measurement properties of smartphone based approaches to assess alcohol use
Louise Thornton, Senior Research Fellow
The Matilda Centre For Research In Mental Health And Substance Use, The University Of Sydney, NSW
Q&A
14:45 – 15:05
Afternoon Tea
15:05 – 16:05
Concurrent Session 7A
Innovative Models of Care
HYBRID SESSION
Concurrent Session 7B
Illicit Drugs & Drug Alert
HYBRID SESSION
Concurrent Session 7C
Alcohol’s Harms to Others
IN PERSON ONLY
Concurrent Session 7D
Suicide & Self-Harm
IN PERSON ONLY
South Australian Initiative to Facilitate COVID-19 Isolation Requirements in Homeless, COVID-positive Aboriginal people with Substance Dependence, including a Managed Alcohol Program
Katherine Senior, Addiction Medicine Advanced Trainee
Drug & Alcohol Services SA, SA
The AusMAP study: a protocol for a randomised, controlled feasibility study of a Managed Alcohol Program in Australia
Brendan Clifford, Clinical Research Coordinator
St Vincent’s Hospital Sydney, NSW
Q&A
Awareness of, and behavioural responses to, drug alerts in Australia: Findings from the Ecstasy and Related Drugs Reporting System and the Illicit Drug Reporting System
Amy Peacock, Program Lead, Drug Trends
National Drug And Alcohol Research Centre, UNSW Sydney, NSW
An Australian National Prompt Response Network for Emerging Drugs
Penelope Hill, Emerging Drugs Research Fellow
National Centre for Clinical Research on Emerging Drugs, NSW
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD) and magic mushrooms
Emma Kopra, PhD Student
King’s College London, United Kingdom
Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review
Krista Siefried, Clinical Research Lead
National Centre for Clinical Research on Emerging Drugs, NSW
Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: a case series
Krista Siefried, Clinical Research Lead
National Centre for Clinical Research on Emerging Drugs, NSW
Q&A
Anne-Marie Laslett, Senior Research Fellow
Centre For Alcohol Policy Research, La Trobe University, VIC
and
Robin Room, Professor
Centre for Alcohol Policy Research, VIC
and
Heng Jiang, Senior Research Fellow
Centre for Alcohol Policy Research, VIC
and
Bree Willoughby, Research Officer
Centre for Alcohol Policy Research, VIC
and
Dan Anderson-Luxford, Research Officer
Centre for Alcohol Policy Research, VIC
A multi-methods study to understand the relationship between alcohol and suicide in Aotearoa New Zealand
Rose Crossin, Lecturer
University Of Otago, New Zealand
The role of illicit and pharmaceutical drugs in non-fatal suicide and self-harm ambulance attendances in young Australians during the COVID-19 pandemic
Naomi Beard, Research Officer
Turning Point, VIC
Suicide and self-harm among people prescribed opioid agonist treatment in New South Wales: a retrospective data linkage study
Samantha Colledge-Frisby, Research Fellow
National Drug Research Institute, VIC
The prevalence of alcohol and other drugs in intentional self-harm fatalities in Victoria, Australia
Georgina Lau, PhD Candidate
Monash University, VIC
Q&A
16:10 – 17:00
Late Breakers and Closing Plenary
HYBRID SESSION
Examining Australian and United States user-reported opioid data on StreetRx, a crowdsourced, drug market surveillance website: 2015-20
Daniel Winter, Research Officer & HDR Candidate
The University of Sydney & Edith Collins Centre, NSW
The tobacco endgame and priority populations: A scoping review
Cheneal Puljevic, Research Fellow/Research Operations Manager
The University Of Queensland, QLD
Similar drinking patterns in underage boys and girls is not evidence of women “catching up” to men
Sarah Callinan, Senior Research Fellow
La Trobe University, VIC
Trends in heroin and other opioid-related harms in Australia, 2003-2020
Jane Akhurst, Postdoctoral research fellow
National Drug And Alcohol Research Centre, UNSW Sydney, NSW
The paradox of drinking amongst young people in Jayapura and Sentani, Papua
Ratih Pertiwi, PhD candidate
The University Of Melbourne, VIC
Poster Prizes
Later Breaker Prizes
Closing Remarks
Invitation to attend APSAD Adelaide 2023
Adolescents / Youth
Service providers’ perspectives on youth-friendly drug and alcohol treatment: preliminary findings
Maja Lindegaard Moensted, University Of Sydney, NSW
Modelling the relationship between environmental and social cognitive determinants of risky drinking among emerging adults
Lily Davidson, University of Queensland, QLD
Polysubstance use profiles among adolescents with early onset cannabis use, and their association with cannabis use frequency and related problems in emerging adulthood
Nina Pocuca, University Of Queensland, QLD
Addictive-like eating behaviours, mental ill-health and substance use in 6,640 early adolescents.
Scarlett Smout, The Matilda Centre, University Of Sydney, NSW
Understanding Patterns of Vaping in Adolescents Attending a Hospital Drug & Alcohol Clinic
Jonathan Chandran, The Children’s Hospital At Westmead, NSW
Prevalence of Parental Supply of Alcohol to Children and Adolescents: A Systematic Review of International Studies
Nathan Harrison, National Centre For Education And Training On Addiction (nceta), SA
The Drinking Motives of Australian Parents
Ashlea Bartram, National Centre For Education And Training On Addiction (nceta), SA
Alcohol
Deep Learning Algorithm to Quantify Alcohol Exposure in Song Lyrics from 1959 to 2020
Abraham Albert Bonela, Centre For Alcohol Policy Research, VIC
The Effectiveness of an Electronic Intervention Involving Personalised Alcohol Intake and Brain Health Feedback to Reduce Alcohol Misuse
Antoinette Poulton, University Of Melbourne, VIC
Now You See Me, Now You Don’t: Do People Underestimate the amount of Alcohol they see in Videos?
Benjamin Riordan, Centre For Alcohol Policy Research, La Trobe University, VIC
Alcohol consumption, the microbiome, and hangover severity
Joris Verster, Utrecht University, Utrecht, The Netherlands
Sydney’s Inner-West micro-brewery tasting bars and development approvals, fact-based or not? An appraisal of documents submitted to Council for development approval
Eugenia Natalia Uthurralt, Sydney Local Health District, NSW
N acetylcysteine in the treatment of alcohol use disorder with or without liver disease: A pilot, randomized, double-blind, placebo-controlled trial
Kirsten Morley, University Of Sydney, NSW
Alcohol negatively impacts subjective and objective measures of sleep in those undergoing overnight sleep assessment in a hospital setting
Rowan Ogeil, Monash University, VIC
Drink in Check – Tackling on-campus drinking cultures
Anne Marieke Bleeker, ATODA, NSW
The effect of N-acetyl cysteine on alcohol cue reactivity in alcohol use disorder: A randomized, placebo-controlled pharmaco-fMRI study
Warren Logge, University Of Sydney, NSW
A Systematic Review of the relationship between alcohol-related media on Social Networking Sites and Alcohol Use
Hsu-Chen Cheng, The University Of Queensland, QLD
Every Moment Matters – a nation-wide project supporting alcohol-free pregnancies and breastfeeding
Sarah Ward, Foundation For Alcohol Research And Education, ACT
Prevalence of harm to children from others’ drinking – a national survey
Cassandra Hopkins, Centre For Alcohol Policy Research, VIC
Evaluation of the FASD Hub Australia Website
Elizabeth Elliott, University Of Sydney, NSW
Blood-Borne Viruses (Incl. STI)
A Baseline Assessment of The Hepatitis C Virus Screening Rate of Patients Enrolled at an Opioid Agonist Treatment Clinic Before the COVID-19 Pandemic
Siyu Qian, Islhd Drug And Alcohol Service, NSW
VEND-C. Evaluating distribution of rapid HCV-antibody self-testing kits via needle/syringe vending machines: A protocol paper
Caitlin Douglass, Burnet Institute, VIC
Cannabis
Chronic Cannabis Use and Error Awareness: The Effect on Learning from Errors
Gezelle Dali, The University Of Melbourne, VIC
Self-reported cannabis expenditure in the USA and Canada by daily and nondaily cannabis users
Carmen Chia Wern Lim, National Centre For Youth Substance Use Research, The University of Queensland, QLD
Systematic review and meta-analysis of the level of cannabis use in the Sub-Saharan region
Habte Gobie, The University Of Queensland, QLD
Children & Families
Healthcare Workers as Mandated Reporters – What is the Evidence? A Narrative Literature Review
Aayushi Talwar, University Of Sydney, NSW
The effectiveness of psychosocial interventions for family members impacted by another’s substance use: A systematic review of the last 10 years
Clare Rushton, University Of Wollongong, NSW
Coercive Treatment
An audit of the Northern Territory Alcohol Mandatory Treatment program
Christine Watson, Top End Health Service, NT
Comorbidity
The effect of stimulants and gender on the relationship between disordered eating and mental health in young people
Laura Robinson, University Of Wollongong, NSW
Longitudinal associations of anxiety and depression among people who primarily smoke methamphetamine
Zoe Duncan, Monash University, VIC
Prevalence of mental disorders among people with opioid use disorder: A Systematic Review and Meta-analysis
Thomas Santo Jr, National Drug & Alcohol Research Centre (NDARC), UNSW Sydney, NSW
COVID-19
Reductions in Alcohol Intake Among Young Adults During the Pandemic Underpinned by Binge Drinkers and Not Related to Changes in Behavioural Impulsivity
Antoinette Poulton, University Of Melbourne, VIC
Improving access to treatment and support for women with Substance Use Disorder during the COVID-19 pandemic- the experience with telehealth from a women’s only service
Latha Nithyanandam, ADFNSW-Kathleen York House, NSW
A novel, flexible drug and alcohol service in response to COVID-19 public health measures in a regional health service in NSW
Charlotte Ismay, Hunter New England Local Health District Drug & Alcohol Clinical Services, NSW
Crime, Justice, & Legal Issues
Trends in drug use and possession in the Northern Territory across 10 years
Timothy Piatkowski, Charles Darwin University, NT
Cross Culture & International
Individual and environmental factors associated with heavy drinking among South African adolescents
Bronwyn Myers, Curtin University, WA
Drug Monitoring / Novel Psychoactive
Developing the NSW surveillance plan for Australia’s Kava Pilot
Jared Brown, Centre For Alcohol and Other Drugs, NSW Ministry of Health, NSW
Examining Australian and United States user-reported opioid data on StreetRx, a crowdsourced, drug market surveillance website: 2015-20
Daniel Winter, The University of Sydney & Edith Collins Centre, NSW
Ecstasy & Emerging Psychoactive Substances
Microdosing amongst people who regularly use ecstasy and other illicit stimulants in Australia, 2021-2022
Caroline Salom, Institute For Social Science Research, UQ, QLD
E-Health – Behavioural Change
Developing a local data informed virtual care framework with drug and alcohol clinicians and consumers in South Eastern Sydney Local Health District
Phillipa Jenkins, NSW Health Seslhd Drug And Alcohol, NSW
Do eHealth interventions targeting poor diet, alcohol use, tobacco smoking and vaping adequately serve adolescents from disadvantaged backgrounds? Findings from a systematic review
Lyra Egan, The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, NSW
Epidemiology
Childhood maltreatment and alcohol problems in young adulthood: coping style as a mediator and potential intervention target
Lucinda Grummitt, The University Of Sydney, NSW
COVID-19 pandemic experiences of people in Australia who inject drugs: Analysis of Illicit Drug Reporting System interview data 2020-2022
Olivia Price, National Drug and Alcohol Research Centre, NSW
Prevalence of substance use in non-transport injury events
Georgina Lau, Monash University, VIC
Action into Policy: How AOD data complement national surveillance systems
Louise Tierney, Australian Institute of Health & Welfare, ACT
First Peoples
Planned vs delivered behaviour change techniques (BCTs) in SISTAQUIT® Smoking Cessation Intervention Materials for Aboriginal and Torres Strait Islander pregnant women: an analysis using multiple taxonomies.
Gina La Hera Fuentes, The University of Newcastle, NSW
Gambling
Gambling in Australia during COVID-19: improving understanding of online gambling ‘sessions’.
Rebecca Jenkinson, Australian Gambling Research Centre, Australian Institute of Family Studies, VIC
The prevalence of gambling and gambling-related harm: a systematic review and meta-analysis of the evidence
Samantha Colledge-Frisby, National Drug Research Institute, VIC
Comparing the factor structure of the Problem Gambling Severity Index: Implications for conceptualisation, measurement, and practice
Kim Caudwell, Charles Darwin University, NT
Do gambling motivations depend on the gambler?
Mal Flack, CDU, NT
Accuracy of self-reported gambling frequency and outcomes: Comparisons with account data.
Robert Heirene
Harms & Harm Reduction
Voices represented and voices silenced: Case study of North Richmond Community Health medically supervised injecting room
Bianca Whiteside, Deakin University, VIC
Understanding Gender Differences in Injecting Risk Behaviour Among an Australian Sample of People Who Inject Drugs
Daisy Gibbs, National Drug and Alcohol Research Centre, UNSW, NSW
A systematic review of interventions to reduce harms associated with alcohol and other drug use in licensed entertainment settings and outdoor music festivals
Christopher Eassey, National Drug and Alcohol Research Centre, NSW
Health Services & Systems
Non-prescribed drug use among hospital inpatients
Winston Kardell, Nepean Blue Mountains Local Health District, NSW
An exploration into response of culturally and linguistically diverse consumers within a multicultural alcohol and other drug service setting during COVID-19: A rapid assessment of experience of consumers and providers.
Neeloy Alam, Drug and Alcohol Multicultural Education Centre (DAMEC), NSW
Characteristics of alcohol and other drug-related ambulance attendances in Australia, 2021
Holly Jian, Australian Institute Of Health And Welfare, ACT
A Training Needs Analysis for the Alcohol and other Drug Information and Support Services (ADIS) for calls relating to Methamphetamine and Emerging Drugs (ADIS MED TNA)
Krista Siefried, National Centre for Clinical Research on Emerging Drugs, NSW
A Medically Supervised Injecting Room as a gateway to health and social support
Nico Clark, North Richmond Community Health, VIC
Value Based Health Care for Drug and Alcohol Services: A NSW approach
Kristie Mammen, DAS SESLHD, NSW
Heroin & Opioids
Iatrogenic Opioid Overdose in an Opioid-Naïve Person Given High-Dose Long-Acting Injectable Buprenorphine
Katherine Senior, Drug & Alcohol Services SA, SA
Increased Cytochrome P450-2D6 activity in people with codeine use disorders.
Mark Daglish, Hospital Alcohol & Drug Service, Metro North Health, QLD
Non-medical use of pharmaceutical opioids with other illicit substance in Australia
Gary Chan, National Centre For Youth Substance Use Research, QLD
Associations with childhood trauma and comorbid mental disorders among people with opioid dependence
Thomas Santo Jr, National Drug & Alcohol Research Centre (NDARC), UNSW Sydney, NSW
Capturing key regulatory activities targeting pharmaceutical opioids in Australia: What has the last decade of policy looked like?
Olya Ryjenko, The University Of Sydney, NSW
Long-term recovery from opioid use disorder: identification of recovery subgroups and their association with opioid use, treatment, and quality of life
Laura Johnston, Indivior, NSW
Long-Term Treatment with BUP-XR in Patients Struggling to Abstain from Opioids
Laura Johnston, Indivior, NSW
Comparison of Depot Buprenorphine versus Oral Opiate treatment in opiate dependent patients in Rural General Practice – a medical record audit of patient self-reported clinical and quality of life outcomes.
Anthony Solomon, NCMC Byron Bay, NSW
Injecting Drug Use
The ‘In The Moment Pilot’. Evaluating methods of in-situ data collection during episodes of injecting drug use to improve opioid overdose response: A protocol paper
Daniel O’Keefe, Burnet Institute, VIC
Managing Suicidal Crisis at the Sydney Medically Supervised Injecting Centre (MSIC)
Kate Hocknull, Uniting MSIC, NSW
LGBTIQ
ReWired: changing the chemsex narrative through peer based responses for same sex attracted men who use methamphetamines
Lucy Burnett, Thorne Harbour Health, VIC
Methamphetamine & Psychostimulants
Methamphetamine use and depression – a systematic review and meta-analysis
Janni Leung, National Centre For Youth Substance Use Research, QLD
Beyond the ice: Differences in biopsychosocial risk factors and neuropsychological profiles among individuals with histories of alcohol or methamphetamine-polysubstance use.
James Gooden, Turning Point, VIC
Correlates of incarceration among people who primarily smoke methamphetamine
Anna McLean, Monash University, VIC
A systematic review of brief interventions for psychostimulant use in primary and acute care settings
Briony Larance, University Of Wollongong, NSW
An exploratory analysis of actigraphy and sleep diaries in a methamphetamine withdrawal clinical trial
Liam Acheson, NCCRED, NSW
A systematic review and meta-analysis of functional, health and cognitive outcomes in young people who use methamphetamine
Alexandre Guerin, University Of Melbourne, VIC
Risk factors for poor oral health related quality of life in a cohort of people who use methamphetamine in Australia
Shady Abdelsalam, National Drug Research Institute, VIC
A study protocol for the PsiMA trial: Psilocybin assisted Psychotherapy for Methamphetamine use disorder
Elizabeth Knock, St Vincents Hospital Sydney, NSW
Neuroscience
Incorporating Neuroimaging into Addiction Neuromodulation Research
Amanda Brown, Hunter New England Health, NSW
Development of a large Australian alcohol beverage picture set to aid neuromodulation research for alcohol use disorders
Madeleine Hinwood, The University of Newcastle, NSW
Neurobehavioral effects of cannabidiol and potential therapeutic mechanisms for alcohol use disorders: A systematic review
Tristan Hurzeler, University of Sydney, NSW
New Technologies & E-Interventions
Frontline Insights and Experience in Delivering a Structured Out-Client Drug and Alcohol Treatment Program via Telehealth
Mieke Waters, The Salvation Army, NSW
Older Adults
Exploring risk perceptions of alcohol consumption among older people
Victoria Kostadinov, National Centre For Education And Training On Addiction, Flinders University, SA
Other AOD Issues
What is the best way to assess drug prices using self-report data?
Cheneal Puljevic, The University Of Queensland, QLD
Alcohol and other drug healthcare staff perceptions regarding client reimbursement for participating in research
Daniel Winter, The University of Sydney & Edith Collins Centre, NSW
Overdose
A retrospective review of hospital admissions for opioid toxicity in South Australia: A 3-year, state-wide study
Maria Sarantou, Flinders University, SA
“Sometimes I Have a Duty of Care Not to Call 000”: Reported Practices, Attitudes and Factors Influencing Consumer Responses to GHB Overdose
Krista Siefried, NCCRED, NSW
Pharmaceuticals (Consumption)
Prescription opioids in Australia 2012–2021: Who was most likely to be dispensed opioids?
Louise Blunden, Australian Institute Of Health And Welfare, ACT
Prescription Opioid Treatment
Interactions between Methadone and Rifampicin: a case series
Jeku Jacob, St Vincent’s Hospital, Sydney, NSW
A retrospective review of patterns of use of long-acting injectable buprenorphine products.
Mark Daglish, Hospital Alcohol & Drug Service, Metro North Health, QLD
Opioid and Cannabis Co-Use among Adults with Chronic Pain: The Role Opioid Use to Cope with Psychological Distress
Julia Buckner, Louisiana State University, Louisiana
Prevention & Early Intervention
Learning with FASD: Development of a national initiative to disseminate evidence-based resources on Fetal Alcohol Spectrum Disorder for primary school teaching and support staff.
Emma Devine, University of Sydney, NSW
Which AUDIT-C cut-off? preliminary results from a systematic review of AUDITC thresholds for males and females
Jane Fischer, National Centre for Education and Training on Addiction (NCETA), SA
Positive Choices: Evaluation of a national initiative to disseminate evidence-based alcohol and other drug education and prevention resources
Emma Devine, University of Sydney, NSW
Social & Community Issues
Engaging men perpetrating domestic and family violence in the alcohol and other drug treatment context
Michelle Ridley, Network Of Alcohol And Other Drugs Agencies, NSW
A novel service delivering addiction medicine treatments to people in Melbourne’s CBD experiencing homelessness
Antony Bolton, Royal Melbourne Hospital, VIC
Special Populations
The unique practices of females using performance and image enhancing drugs (PIEDs)
Timothy Piatkowski, Charles Darwin University, NT
A systematic review investigating the psychosocial factors influencing initiation, use, and subjective experience of performance and image-enhancing drugs (PIEDs) in female weight-training populations
Hannah Schuurs, Uq School Of Psychology, QLD
Tobacco & Tobacco Cessation
Predicting the long-term effect of e-cigarette use on population health: A systematic review of modelling studies
Giang Vu, National Centre For Youth Substance Use Research, QLD
Does second-hand smoking mass-media campaign increase public awareness and reduce second-hand smoke exposure? A systematic review
Carmen Chia Wern Lim, National Centre For Youth Substance Use Research, The University of Queensland, QLD
A content analysis of illicit tobacco-related crimes reported in Australian media
Cheneal Puljevic, The University Of Queensland, QLD
The impact of tobacco control policies on the illicit tobacco market: A scoping review
Cheneal Puljevic, The University Of Queensland, QLD
Adolescent exposure to advertisements and promotions for tobacco products on the internet
Janni Leung, National Centre For Youth Substance Use Research, QLD
The Role of Peer Interaction on Indonesian Adolescent Smoking Behavior: Prevalence, Incidence, and Psychosocial Predictors
Ghea Farassania, Research Of Community Mental Health Initiative, Faculty of Psychology, Universitas Indonesia, Jawa Barat
Implementation strategies to increase smoking cessation treatment provision in primary care: a systematic review of observational studies
Bernadett Erika Tildy, King’s College London, Cheshire
Perceived Loneliness, Peer and Parental Relationship with Smoking: A Cross-sectional Analysis of 64,578 Adolescents across South-East Asia
Caitlin McClure-Thomas, National Centre For Youth Substance Use Research, QLD
An exploration of the patient experience of and attitudes towards Vaporised Nicotine Products as a means to achieve Smoking Cessation in opiate agonist treatment patients.
Kirsten Wright, University Of Newcastle, NSW
Baseline findings from Project NEAT: Nicotine as treatment for tobacco smoking
Jane Rich, University Of Newcastle, NSW
Market trends and distribution of electronic cigarette flavours
Caitlin Jenkins, University Of Wollongong, NSW
Effectiveness, safety and cost-effectiveness of vaporised nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: A study protocol for a randomized controlled trial
Bridget Howard, National Drug And Alcohol Research Centre, VIC
Outback Quit Pack pilot RCT trial: mailout NRT and Quitline support for people in rural, regional and remote areas who smoke
Ashleigh Guillaumier, University Of Newcastle, NSW
Can e-cigarettes assist opiate agonist treatment clients to quit smoking? Preliminary results from HARMONY, a multi-site, single-blind RCT of e-cigarettes and NRT
Emma Austin, Hunter New England Local Health District Drug & Alcohol Clinical Services, NSW
Global prevalence of heated tobacco product use, 2015 – 2021: a systematic review and meta-analysis.
Tianze Sun, The National Centre For Youth Substance Use Research, QLD
Mental health and tobacco endgame strategy support in South Australia
Joshua Trigg, Flinders University, SA
Nicotine in addictions: The myth that nicotine is benign
Renee Bittoun, University Of Notre Dame, NSW
Trends of Youth Multiple Tobacco and/or Cigarette Product Use in the United States
Tianze Sun, The National Centre For Youth Substance Use Research, QLD
The Development and Evaluation of a Universl School-Based Prevention Intervention Targeting E-Cigarettes: The Ourfutures Vaping Module
Amy-Leigh Rowe, The Matilda Centre, The University Of Sydney, NSW
Translational Research
Relationship between clinician-level attributes and implementation outcomes from the Pathways to Comorbidity Care training program.
Eva Louie, The University of Sydney, NSW
The School-led Preventure study: translation of a personality-targeted substance use prevention program in Australia
Lucinda Grummitt, The University of Sydney, NSW
Treatment & Interventions
Reaching consensus on the most important measures of performance for NSW non government alcohol and other drugs treatment services
Robert Stirling, Network of Alcohol and Other Drug Agencies, NSW
The impact of COVID–19 on service delivery from alcohol and other drug treatment services
Willow Bryant, Australian Institute of Health and Welfare, ACT
Prevalence of participation in a tobacco, alcohol or other drug treatment program – findings from the 2019 Australian National Drug Strategy Household Survey
Tesfa Mekonen, The University of Queensland, QLD
Patient-reported outcomes of subcutaneous depot buprenorphine treatment in Australian correctional centresp
Bethany White, Edith Collins Centre, SLHD, NSW
Can a telephone-delivered intervention for methamphetamine use problems overcome barriers to treatment?
Rachel Petukhova, Turning Point, VIC
Investigating the critical period for alcohol or drug-related re-presentations following discharge from residential treatment: A data linkage study.
Calvert Tisdale, Lives Lived Well Research Group, School of Psychology, The University of Queensland, QLD
Long-acting injectable buprenorphine: A qualitative study of consumers’ experiences of care in Australia
Anthony Barnett, Turning Point, Monash University, VIC
Ketamine-facilitated high dose opioid rotation in a patient who has chronic non-cancer pain – case study
Pem Ariyawansa, Aods Gold Coast University Hospital, QLD
Severity and outcomes of inpatient admissions for gamma hydroxy-butyrate withdrawal amidst COVID-19 pandemic in South Western Sydney
Ricky Harjanto, NSW
Treatment Settings
SMART Track: Feasibility and implementation of a Smart Phone App for SMART Recovery
Peter Kelly, University of Wollongong, NSW
Alcohol and other drug treatment clients’ experiences of telehealth during the COVID-19 pandemic
Rachel Petukhova, Turning Point, VIC
Clients Entering New South Wales (NSW) Alcohol and Other Drug (AOD) Treatment Services: Characteristics by Principal Drug of Concern (PDOC), July 2016-June 2019
Emma Black, Drug and Alcohol Services, South Eastern Sydney Local Health District, NSW
Addressing Substance Use Disorders in Humanitarian Settings – Access to Health and Social Services for Displaced Populations and Host Communities in Acute and Protracted Emergencies
Anja Busse, Unodc, Vienna
Well At Work
Predictors of Alcohol and Drug-related Absenteeism in Australia
Alice Mcentee, Flinders University, SA
Women & Maternal Issues
Antenatal Care Engagement Among Pregnant Women who Identify Methamphetamine as the Primary Substance of Concern
Siyu Qian, Islhd Drug And Alcohol Service, NSW
Characteristics of Clients Entering Women-Only Substance Use Treatment Services in NSW, 2014-2018
Eugenia Natalia Uthurralt, Sydney Local Health District, NSW
Pregnancy register for women who have had children whilst on modified release subcutaneous buprenorphine formulations
Adrian Dunlop, HNE Health – Drug And Alcohol Clinical Services, NSW
Workforce Issues
Workforce Development in AOD, a Response to COVID-19
Fay Staios, Turning Point, VIC
Rising educational attainment in the alcohol and other drug sector: evidence and implications
Elisabeth Yarbakhsh, ATODA, ACT
Factors associated with retention of regional and remote Australian AOD workers: an exploratory study
Jane Fischer, National Centre For Education And Training On Addiction (nceta), SA
The Role of Community Pharmacy in the Alcohol and Other Drug (AOD) Workforce
Chloe Langfield, Cooleman Court Pharmacy, ACT